Clover Health Investments (CLOV) Change in Receivables (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Change in Receivables data on file, last reported at -$21.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 1174.97% year-over-year to -$21.4 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (up 165.74% YoY), and the FY2025 full-year result was $43.3 million, up 443.18% from the prior year.
• Change in Receivables for Q1 2026 stood at -$21.4 million, down from $36.9 million in the prior quarter.
• Across five years, Change in Receivables topped out at $36.9 million in Q4 2025 and bottomed at -$29.4 million in Q3 2024.
• The 5-year median for Change in Receivables is $2.0 million (2025), against an average of $1.5 million.
• The widest annual swing landed in 2022, when Change in Receivables surged 306.9%; it then sank 2379.85% in 2023.
• A 5-year view of Change in Receivables shows it stood at $13.8 million in 2022, then dropped by 12.14% to $12.1 million in 2023, then increased by 17.65% to $14.2 million in 2024, then soared by 159.58% to $36.9 million in 2025, then slumped by 157.93% to -$21.4 million in 2026.
• The last three Change in Receivables figures came in at -$21.4 million (Q1 2026), $36.9 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.

Peer Comparison